87357-67-3

Basic information

• Product Name: R-(3)-BENZYLOXYMYRISTIC ACID
• Synonyms: R-(3)-BENZYLOXYMYRISTIC ACID;(R)-3-BENZYLOXYTETRADECONOIC ACID;(R)-3-Benzyloxytetradecanoic Acid;(3R)-3-(PhenylMethoxy)tetradecanoic Acid
• CAS NO: 87357-67-3
• Molecular Formula: C₂₁H₃₄O₃
• Molecular Weight: 334.49
• Product Categories: Mixed Fatty Acids;Fatty Acid Derivatives & Lipids;Glycerols;Aromatics
• Mol File: 87357-67-3.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 457.33°C at 760 mmHg
• Flash Point: 149.643°C
• Appearance: /
• Density: 0.989g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.499
• Storage Temp.: Refrigerator
• Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
• CAS DataBase Reference: R-(3)-BENZYLOXYMYRISTIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: R-(3)-BENZYLOXYMYRISTIC ACID(87357-67-3)
• EPA Substance Registry System: R-(3)-BENZYLOXYMYRISTIC ACID(87357-67-3)

Safety Data

• Hazardous Substances Data: 87357-67-3(Hazardous Substances Data)

Usage

Chemical Properties

Light Yellow Liquid

InChI:InChI=1/C21H34O3/c1-2-3-4-5-6-7-8-9-13-16-20(17-21(22)23)24-18-19-14-11-10-12-15-19/h10-12,14-15,20H,2-9,13,16-18H2,1H3,(H,22,23)/t20-/m1/s1

Upstream product

• 87357-66-2 phrnacyl (R)-3-(benzyloxy)tetradecanoate 
• 114264-01-6 methyl (R)-3-(benzyloxy)tetradecanoate 
• 143152-69-6 tert-butyl (R)-3-benzyloxytetradecanoate 
• 76062-97-0 methyl (R)-3-hydroxytetradecanoate 
• 186383-49-3 2-(4-bromophenyl)-2-oxoethyl (R)-3-hydroxytetradecanoate 
• 100-52-7 benzaldehyde 
• 28715-21-1 (R)-3-hydroxytetradecanoic acid 
• 87357-65-1 (3R)-3-hydroxytetradecanoic acid phenacyl ester 
• 79816-65-2 tert-butyl (R)-3-hydroxytetradecanoate 
• 163660-02-4 tert-butyl (R)-3-acetoxytetradecanoate 
• 163562-86-5 tert-butyl (2R,3R)-3-acetoxy-2-chlorotetradecanoate 
• 81927-55-1 O-benzyl 2,2,2-trichloroacetimidate 
• 100-39-0 benzyl bromide 
• 139623-16-8 (R)-3-benzyloxy-1-hydroxytetradecane 

Downstream Products

• 101649-06-3 N-((R)-3-Benzyloxytetradecanoyloxy)succinimid 
• 92949-61-6 allyl 4-O-benzyl-6-O-<6-O-benzyloxymethyl-3-O-<(R)-3-benzyloxytetradecanoyl>-2-<(R)-3-benzyloxytetradecanoylamino>-2-deoxy-β-D-glucopyranosyl>-3-O-<(R)-3-benzyloxytetradecanoyl>-2-<(R)-3-benzyloxytetradecanoylamino>-2-deoxy-β-D-glucopyranoside 4'-... 
• 99519-07-0 allyl 2-<(R)-3-benzyloxytetradecanamido>-3-O-<(R)-3-benzloxytetradecanoyl>-2-deoxy-4,6-isopropylidene-β-D-glucopyranoside 
• 98889-64-6 allyl 3-O-<(R)-3-benzyloxytetradecanoyl>-2-deoxy-4,6-O-isopropylidene-2-(2,2,2-trichloroethoxycarbonylamino)-α-D-glucopyranoside 
• 104495-57-0 Allyl 4-O-benzyl-6-O-<3-O-<(R)-3-benzyloxytetradecanoyl>-2-<(R)-3-benzyloxytetradecanoylamino>-2-deoxy-4,6-O-isopropylidene-β-D-glucopyranosyl>-2-deoxy-3-O-(2,2,2-trichloro-tert-butoxycarbonyl)-2-(2,2,2-trichloro-tert-butoxycarbonylamino)-β-D-gluco... 
• 118638-71-4 2-acetoxyethyl 3,4,6-tri-O-acetyl-2-<(R)-3-benzyloxytetradecanoylamino>-2-deoxy-α-D-glucopyranoside 
• 87357-71-9 C₁₂₇H₁₉₄N₂O₁₉ 
• 93390-33-1 (R)-3-Benzyloxy-tetradecanoic acid (2R,3R,4R,5S,6R)-2-allyloxy-5-benzyloxy-6-benzyloxymethyl-3-((R)-3-benzyloxy-tetradecanoylamino)-tetrahydro-pyran-4-yl ester 
• 98870-61-2 (R)-3-Benzyloxy-tetradecanoic acid (4aR,6S,7R,8R,8aS)-6-allyloxy-7-((R)-3-benzyloxy-tetradecanoylamino)-2,2-dimethyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yl ester 
• 88862-41-3 C₇₁H₁₀₆N₂O₁₅ 
• 92949-55-8 allyl 6-O-<3,4,6-tri-O-acetyl-2-<(R)-3-benzyloxytetradecanoylamino>-2-deoxy-β-D-glucopyranosyl>-3-O-benzoyl-4-O-benzyl-2-<(R)-3-benzyloxytetradecanoylamino>-2-deoxy-β-D-glucopyranoside 
• 87357-70-8 C₁₀₉H₁₆₆N₂O₁₇ 
• 92949-57-0 C₁₀₉H₁₆₆N₂O₁₇ 
• 88862-42-4 C₈₉H₁₃₄N₂O₁₇ 

Relevant articles and documents

BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPY

The invention relates to a bifunctional compound that is, on one side, an agonist of the TLR4 and, on the other side, an important inhibitor of the PSMA. Said compound is useful in immunotherapy for the treatment and/or prevention of prostate cancer. Therefore, the invention also relates to the use of the compound and to the pharmaceutical composition comprising it.

SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF

In one aspect, the present disclosure provides compounds of formulae (I) and (II). In another aspect, a compound of formula (I) or (II) is formulated into compositions with an antigen, optionally with a vesicle. In some embodiments, compositions are administered intramuscularly.

Preparation of a lipid A derivative that contains a 27-hydroxyoctacosanoic acid moiety

(Chemical Equation Presented) A general synthetic strategy for long-chain ω-1 hydroxy fatty acids has been developed, which employs as a key reaction step a cross metathesis between ω-unsaturated ester and 3-butene-2-ol. The resulting lipids were used for